FDA Inspection 1030012 — NYU Langone Reproductive Specialists Of New York

NYU Langone Reproductive Specialists Of New York — FEI 3003972384

The FDA completed an inspection of NYU Langone Reproductive Specialists Of New York on Oct 27, 2017 in Mineola, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 27, 2017
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mineola, NY (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1222921 CFR 1271.50(a)Determination based on screening and testing

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.